Kenneth P. Thompson Begin Again Act This bill expands eligibility for the expungement of records related to a first-time drug possession offense. Current law permits expungement for offenders who commit the offense before age 21. This bill permits expungement for offenders who commit the offense at any age.
HRES 1028 is a symbolic House resolution supporting the current legal standard for securities disclosure, which requires companies to share only information investors deem "material" (important to their investment decisions). It opposes new disclosure rules - particularly those focused on environmental, social, and governance (ESG) issues - that would expand beyond the SEC’s core mission of investor protection and market fairness. The resolution argues such changes would burden businesses with costly compliance, create information overload for investors, and distract the SEC from its primary role. It specifically references the decades-old materiality standard established by the 1933 Securities Act and reinforced by the 1976 Supreme Court case *TSC Industries v. Northway*. As a resolution, it does not change law but expresses congressional preference against expanding disclosure requirements.
Modernizing Therapeutic Equivalence Rating Determination Act This bill requires the Food and Drug Administration (FDA) to provide a therapeutic equivalence rating for certain new drug applications if the applicant requests such a rating. Upon request in the application, the FDA must provide such a rating for a new drug application that relies on information from studies not conducted by the applicant and that the applicant does not have a right to reference or use (commonly referred to as a 505(b)(2) application). The FDA must provide the rating no later than 30 days after the application's approval. (A drug is a therapeutic equivalent of another if they produce the same clinical effect and have the same safety profile. Typically, for certain generic drugs, the FDA rates the therapeutic equivalence of that generic drug to another drug, such as the brand name version. Currently, an applicant seeking approval of a drug through a 505(b)(2) application typically only receives an equivalence rating by requesting one from the FDA in a separate petition.)
Ensuring Lasting Smiles Act This bill requires private health insurance plans to cover diagnosis and treatment of congenital anomalies and birth defects, such as reconstructive services and items. Coverage must include services and items that functionally improve, repair, or restore any body part that is medically necessary for normal bodily functions or appearance, as determined by the treating physician. Coverage limits and cost-sharing requirements for such services and items may not be more restrictive than those applicable to all medical and surgical benefits under the plan.
This resolution calls on the Biden administration and its officials to maintain the sanctions on the repressive regimes in Venezuela and Iran. The resolution also expresses the sense of the House of Representatives that American energy independence should be achieved again for the sake of U.S. national security and the security of U.S. allies; and President Biden should immediately rescind his Executive Orders that prohibit the approval of new leases on federal lands and waters, and should immediately take actions to reestablish American energy independence.
Supply Chain Disruptions Relief Act This bill modifies the treatment of liquidations of new motor vehicle inventory as qualified LIFO (last in first out accounting method) inventory. It allows new motor vehicle dealers to elect to wait until the end of 2025 to replace their inventory for purposes of determining income attributable to the sale of such inventory during 2020 and 2021.
John W. Walsh Alpha-1 Home Infusion Act of 2022 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.
SRES 565 is a ceremonial Senate resolution honoring the late Representative Don Young (R-AK), who served 49 years in the U.S. House of Representatives - the longest tenure of any Alaska representative and the 45th Dean of the House. The resolution commemorates his life, service, and legacy, including his work on landmark legislation like the Trans-Alaska Pipeline authorization and the Alaska Native Claims Settlement Act. It contains no policy changes or new laws; instead, it directs the Senate to mourn his passing, honor his bipartisan service, and transmit a copy to his family. This is a purely symbolic resolution with no direct impact on constituents or legislation.
Protection and Advocacy for Voting Access Program Inclusion Act or the PAVA Inclusion Act This bill authorizes the Department of Health and Human Services to distribute Protection and Advocacy for Voting Access (PAVA) program grants to the protection and advocacy systems of the Commonwealth of the Northern Mariana Islands and the American Indian consortium.
This resolution supports the preservation of the stepped-up basis tax rule that allows recipients of inherited assets such as land, equipment, or buildings to adjust the cost basis of the assets to reflect their fair market value. The resolution opposes any efforts to impose new taxes on family farms or small businesses and recognizes the importance of generational transfers of farm and family-owned businesses.
Stop Fentanyl Border Crossings Act This bill authorizes the Department of Health and Human Services (HHS) to restrict migration and imports from foreign countries to prevent the introduction of illicit drugs into the United States. Current law authorizes HHS to restrict migration and imports from foreign countries to prevent the introduction of communicable diseases. Under this bill, HHS may also restrict migration and imports from a country if HHS determines that the existence of substantial illicit drug smuggling from that country poses a risk to public health.
Unleashing American Energy Act This bill requires a minimum amount of oil and gas lease sales a year on certain submerged lands of the Outer Continental Shelf (OCS) and limits delays on federal oil and gas leases on such lands. Specifically, this bill requires the Department of the Interior to annually conduct a minimum of two region-wide oil and gas lease sales in each of the following regions of the OCS: (1) the Gulf of Mexico region in the Central Gulf of Mexico Planning Area and the Western Gulf of Mexico Planning Area, and (2) the Alaska region. In addition, the bill requires the President to obtain congressional approval before delaying federal oil and gas leases on the OCS.
